• 1
    Ducy P, Schinke T, Karsenty G 2000 The osteoblast: A sophisticated fibroblast under central surveillance. Science 289: 15011504.
  • 2
    Gierthy JF, Silkworth JB, Tassinari M, Stein GS, Lian JB 1994 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits differentiation of normal diploid rat osteoblasts in vitro. J Cell Biochem 54: 231238.
  • 3
    Safe S 2001 Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol Lett 120: 17.
  • 4
    Willey JJ, Stripp BR, Baggs RB, Gasiewicz TA 1998 Aryl hydrocarbon receptor activation in genital tubercle, palate, and other embryonic tissues in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-responsive lacZ mice. Toxicol Appl Pharmacol 151: 3344.
  • 5
    White TE, Gasiewicz TA 1993 The human estrogen receptor structural gene contains a DNA sequence that binds activated mouse and human Ah receptors: A possible mechanism of estrogen receptor regulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Biophys Res Commun 193: 956962.
  • 6
    Iwano S, Nukaya M, Saito T, Asanuma F, Kamataki T 2005 A possible mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun 335: 220226.
  • 7
    Dertinger SD, Nazarenko DA, Silverstone AE, Gasiewicz TA 2001 Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo[a]pyrene- and cigarette smoke condensate-induced cytogenetic damage in vivo. Carcinogenesis 22: 171177.
  • 8
    Dertinger SD, Silverstone AE, Gasiewicz TA 1998 Influence of aromatic hydrocarbon receptor-mediated events on the genotoxicity of cigarette smoke condensate. Carcinogenesis 19: 20372042.
  • 9
    Gebremichael A, Tullis K, Denison MS, Cheek JM, Pinkerton KE 1996 Ah-receptor-dependent modulation of gene expression by aged and diluted sidestream cigarette smoke. Toxicol Appl Pharmacol 141: 7683.
  • 10
    Henry EC, Gasiewicz TA 1993 Transformation of the aryl hydrocarbon receptor to a DNA-binding form is accompanied by release of the 90 kDa heat-shock protein and increased affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem J 294: 95101.
  • 11
    Xu C, Li CY, Kong AN 2005 Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28: 249268.
  • 12
    Schrenk D 1998 Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics. Biochem Pharmacol 55: 11551162.
  • 13
    Jain S, Maltepe E, Lu MM, Simon C, Bradfield CA 1998 Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse. Mech Dev 73: 117123.
  • 14
    Abbott BD, Schmid JE, Pitt JA, Buckalew AR, Wood CR, Held GA, Diliberto JJ 1999 Adverse reproductive outcomes in the transgenic Ah receptor-deficient mouse. Toxicol Appl Pharmacol 155: 6270.
  • 15
    Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S, Nebert DW, Rudikoff S, Ward JM, Gonzalez FJ 1995 Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268: 722726.
  • 16
    Fernandez-Salguero PM, Ward JM, Sundberg JP, Gonzalez FJ 1997 Lesions of aryl-hydrocarbon receptor-deficient mice. Vet Pathol 34: 605614.
  • 17
    Lahvis GP, Lindell SL, Thomas RS, McCuskey RS, Murphy C, Glover E, Bentz M, Southard J, Bradfield CA 2000 Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci USA 97: 1044210447.
  • 18
    Schmidt JV, Su GH, Reddy JK, Simon MC, Bradfield CA 1996 Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 93: 67316736.
  • 19
    Thackaberry EA, Bedrick EJ, Goens MB, Danielson L, Lund AK, Gabaldon D, Smith SM, Walker MK 2003 Insulin regulation in AhR-null mice: Embryonic cardiac enlargement, neonatal macrosomia, and altered insulin regulation and response in pregnant and aging AhR-null females. Toxicol Sci 76: 407417.
  • 20
    Klein RF, Wiren KM 1993 Regulation of osteoblastic gene expression by lead. Endocrinology 132: 25312537.
  • 21
    Pounds JG, Long GJ, Rosen JF 1991 Cellular and molecular toxicity of lead in bone. Environ Health Perspect 91: 1732.
  • 22
    Ronis MJ, Badger TM, Shema SJ, Roberson PK, Shaikh F 1998 Effects on pubertal growth and reproduction in rats exposed to lead perinatally or continuously throughout development. J Toxicol Environ Health A 53: 327341.
  • 23
    Carmouche JJ, Puzas JE, Zhang X, Tiyapatanaputi P, Cory-Slechta DA, Gelein R, Zuscik M, Rosier RN, Boyce BF, O'Keefe RJ, Schwarz EM 2005 Lead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency. Environ Health Perspect 113: 749755.
  • 24
    Schanne FA, Dowd TL, Gupta RK, Rosen JF 1989 Lead increases free Ca2+ concentration in cultured osteoblastic bone cells: Simultaneous detection of intracellular free Pb2+ by 19F NMR. Proc Natl Acad Sci USA 86: 51335135.
  • 25
    Korashy HM, El-Kadi AO 2004 Differential effects of mercury, lead and copper on the constitutive and inducible expression of aryl hydrocarbon receptor (AHR)-regulated genes in cultured hepatoma Hepa 1c1c7 cells. Toxicology 201: 153172.
  • 26
    Gasiewicz TA, Kende AS, Rucci G, Whitney B, Willey JJ 1996 Analysis of structural requirements for Ah receptor antagonist activity: Ellipticines, flavones, and related compounds. Biochem Pharmacol 52: 17871803.
  • 27
    Zhou JG, Henry EC, Palermo CM, Dertinger SD, Gasiewicz TA 2003 Species-specific transcriptional activity of synthetic flavonoids in guinea pig and mouse cells as a result of differential activation of the aryl hydrocarbon receptor to interact with dioxin-responsive elements. Mol Pharmacol 63: 915924.
  • 28
    Declercq H, Van den Vreken N, De Maeyer E, Verbeeck R, Schacht E, De Ridder L, Cornelissen M 2004 Isolation, proliferation and differentiation of osteoblastic cells to study cell/biomaterial interactions: Comparison of different isolation techniques and source. Biomaterials 25: 757768.
  • 29
    Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB 1990 Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 143: 213221.
  • 30
    Filbrandt CR, Wu Z, Zlokovic B, Opanashuk L, Gasiewicz TA 2004 Presence and functional activity of the aryl hydrocarbon receptor in isolated murine cerebral vascular endothelial cells and astrocytes. Neurotoxicology 25: 605616.
  • 31
    Henry EC, Rucci G, Gasiewicz TA 1994 Purification to homogeneity of the heteromeric DNA-binding form of the aryl hydrocarbon receptor from rat liver. Mol Pharmacol 46: 10221027.
  • 32
    Bronckers AL, Gay S, Finkelman RD, Butler WT 1987 Developmental appearance of Gla proteins (osteocalcin) and alkaline phosphatase in tooth germs and bones of the rat. Bone Miner 2: 361373.
  • 33
    Li W, Harper PA, Tang BK, Okey AB 1998 Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells: CYP1A2 expression in the LS180 colon carcinoma cell line after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 3-methylcholanthrene. Biochem Pharmacol 56: 599612.
  • 34
    Puga A, Hoffer A, Zhou S, Bohm JM, Leikauf GD, Shertzer HG 1997 Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem Pharmacol 54: 12871296.
  • 35
    Puzas JE, Sickel MJ, Felter ME 1992 Osteoblasts and chondrocytes are important target cells for the toxic effects of lead. Neurotoxicology 13: 783788.
  • 36
    Steenhout A 1982 Kinetics of lead storage in teeth and bones: An epidemiologic approach. Arch Environ Health 37: 224231.
  • 37
    Campbell JR, Rosier RN, Novotny L, Puzas JE 2004 The association between environmental lead exposure and bone density in children. Environ Health Perspect 112: 12001203.
  • 38
    Naruse M, Otsuka E, Naruse M, Ishihara Y, Miyagawa-Tomita S, Hagiwara H 2004 Inhibition of osteoclast formation by 3-methylcholanthrene, a ligand for arylhydrocarbon receptor: Suppression of osteoclast differentiation factor in osteogenic cells. Biochem Pharmacol 67: 119127.
  • 39
    Tang CH, Yang RS, Huang TH, Lu DY, Chuang WJ, Huang TF, Fu WM 2006 Ultrasound stimulates cyclooxygenase-2 expression and increases bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblasts. Mol Pharmacol 69: 20472057.
  • 40
    Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, Ozbek U 2006 Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Am J Hematol 81: 162170.
  • 41
    Napoli N, Villareal DT, Mumm S, Halstead L, Sheikh S, Cagaanan M, Rini GB, Armamento-Villareal R 2005 Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density. J Bone Miner Res 20: 232239.
  • 42
    Seidel SD, Winters GM, Rogers WJ, Ziccardi MH, Li V, Keser B, Denison MS 2001 Activation of the Ah receptor signaling pathway by prostaglandins. J Biochem Mol Toxicol 15: 187196.
  • 43
    Zhou J, Gasiewicz TA 2003 3′-methoxy-4'-nitroflavone, a reported aryl hydrocarbon receptor antagonist, enhances Cyp1a1 transcription by a dioxin responsive element-dependent mechanism. Arch Biochem Biophys 416: 6880.
  • 44
    Pollenz RS 2002 The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem Biol Interact 141: 4161.
  • 45
    Franc MA, Pohjanvirta R, Tuomisto J, Okey AB 2001 In vivo up-regulation of aryl hydrocarbon receptor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in a dioxin-resistant rat model. Biochem Pharmacol 62: 15651578.